DNAPrint Historical Income Statement
| DNAG Stock | USD 0.00001 0.00 0.00% |
Historical analysis of DNAPrint Genomics income statement accounts such as Total Revenue of 2.9 M or Gross Profit of 910.5 K can show how well DNAPrint Genomics performed in making a profits. Evaluating DNAPrint Genomics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of DNAPrint Genomics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining DNAPrint Genomics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DNAPrint Genomics is a good buy for the upcoming year.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. About DNAPrint Income Statement Analysis
DNAPrint Genomics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to DNAPrint Genomics shareholders. The income statement also shows DNAPrint investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
DNAPrint Genomics Income Statement Chart
Total Revenue
Total revenue comprises all receipts DNAPrint Genomics generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of DNAPrint Genomics minus its cost of goods sold. It is profit before DNAPrint Genomics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from DNAPrint Genomics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into DNAPrint Genomics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.At this time, DNAPrint Genomics' Research Development is most likely to increase significantly in the upcoming years.
| 2010 | 2011 | 2024 | 2025 (projected) | Gross Profit | 29K | 754.1K | 867.2K | 910.5K | Total Revenue | 33K | 2.4M | 2.8M | 2.9M |
DNAPrint Genomics income statement Correlations
Click cells to compare fundamentals
DNAPrint Genomics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
When determining whether DNAPrint Genomics is a strong investment it is important to analyze DNAPrint Genomics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DNAPrint Genomics' future performance. For an informed investment choice regarding DNAPrint Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DNAPrint Genomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DNAPrint Genomics. If investors know DNAPrint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DNAPrint Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DNAPrint Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DNAPrint Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNAPrint Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.